Deczuba 50mg Injection

Introduction to Deczuba 50 mg Injection

Deczuba 50mg Injection is used in the treatment of blood cancer called Acute Myeloid Leukaemia (AML). It is also used to treat patients with myelodysplastic syndrome (MDS). It may be used to treat other conditions, as determined by the doctor.

The injection is typically administered intravenously by a healthcare professional, usually in a hospital or specialized clinic. The dosing schedule and duration of treatment depend on the type of cancer being treated and the patient’s overall health and response to the medication. Deczuba is often used for cancers such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), conditions where abnormal blood cell production occurs.

Before taking it, tell your doctor if have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses of Deczuba 50 mg 

• Myelodysplastic syndrome
• Blood cancer

How Does Deczuba 50 Works?

Deczuba 50 mg Injection has an active ingredient; Decitabine. Decitabine is a hypomethylating agent which hypomethylates DNA by inhibiting DNA methyltransferase. Decitabine incorporates into DNA strands upon replication. After that when DNA methyltransferases (DNMTs), are engaged to bind to the DNA & to replicate the methylation to the daughter strand, DNMTs are bound to Decitabine irretrievably & cannot disengage.

Therefore, the action of Decitabine is division-dependant, which means the cells have to divide in order for the pharmaceutical to act. Therefore, cancer cells which divide much faster than most other cells in the body will be severely affected by Decitabine because they replicate more.

Side Effects of Deczuba 50

Common Side Effects

• Nausea and Vomiting
• Fatigue
• Low Blood Cell Counts
• Fever
• Appetite Loss
• Diarrhea

Serious Side Effects

• Severe Bone Marrow Suppression
• Infections
• Severe Bleeding
• Liver Problems
• Kidney Issues

Rare Side Effects

• Pulmonary
• Neurological Effects
• Cardiovascular Issues
• Severe Gastrointestinal Reactions

Dosage of Deczuba 50 mg

Deczuba 50 mg Injection contains an active ingredient, Decitabine, which is used in the treatment of ovarian cancer, head & neck cancer, Testicular cancer, cervical cancer, breast cancer,  blood cancer, non-Hodgkin lymphoma (NHL), lung cancer, bone cancer & urinary bladder cancer. This medicine is accessible in different substitutes & strengths & must be purchased or given on doctor’s prescription only. You must consult your physician for dosage and time because age and severity of the disease differ from person to person and it can only be judged by your doctor.

Adults are advised to take Deczuba 50 mg Injection at a fixed time with or without food as instructed by your Doctor. You must take Deczuba 50 mg Injection regularly on time for better results.

Warning & Precautions

• Allergy
• Liver/kidney disease
• Regular monitoring of complete blood cell counts and kidney function is necessary during treatment with this medicine
• You must not drive or operate heavy machinery while taking this medicine as it may cause nausea and vomiting
• You must use a reliable contraceptive method to prevent pregnancy while you are taking this medicine
• Always consult with your doctor straight away to get best possible treatment if you are observing any of the above mentioned conditions

Frequently Asked Questions

1. Is Deczuba 50mg Injection a vesicant?

Ans. Deczuba 50mg Injection is not a vesicant and is not known to cause severe local tissue damage upon extravasation (leaking of injected Deczuba 50mg Injection into the surrounding tissues from the site of administration) when injected.

2. How effective is Deczuba 50mg Injection?

Ans. The effectiveness of Deczuba 50mg Injection depends upon several factors including the patient’s clinical condition, number of treatment cycles etc. and may vary depending upon the individual response.

3. Does Deczuba 50mg Injection cause hair loss?

Ans. Yes. Hair loss (alopecia) is among the known side effects of Deczuba 50mg Injection.

4. How is Deczuba 50mg Injection administered?

Ans. Deczuba 50mg Injection comes as a powder to be to be added to fluid and injected slowly over 3 hours into a vein (slow i.v infusion) by a doctor who is experienced in giving chemotherapy medications for cancer in a hospital or a clinic.